PAPADOPOULOS STELIOS
SEC insider (Form 3/4/5 filer). CIK 0001202098. Director at EXELIXIS, INC. (EXEL) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in NEW YORK, NY.
Companies PAPADOPOULOS STELIOS has filed insider reports for
- EXELIXIS, INC. (EXEL): Director
- Ovid Therapeutics Inc. (OVID): Director
- Regulus Therapeutics Inc. (RGLS): Director
PAPADOPOULOS STELIOS
CIK: 0001202098
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 27, 2026EXEL
EXELIXIS, INC.
AwardDirect8.4K shares- - Apr 7, 2026OVID
Ovid Therapeutics Inc.
AwardDirect17.6K shares at avg. $2.56$45K - Feb 26, 2026OVID
Ovid Therapeutics Inc.
AwardDirectEmployee Stock Option (Right to Buy)
65K shares- - Nov 12, 2025EXEL
EXELIXIS, INC.
SaleDirect100K shares at avg. $43.55$4.4M - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
Tender OfferDirect976.3K shares- - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect64.6K shares- - May 29, 2025EXEL
EXELIXIS, INC.
AwardDirect9.8K shares- - May 15, 2025EXEL
EXELIXIS, INC.
ExerciseDirect20.6K shares at avg. $19.77$408K - May 15, 2025EXEL
EXELIXIS, INC.
ExerciseDirect15.9K shares at avg. $20.50$325K - May 15, 2025EXEL
EXELIXIS, INC.
SaleDirect15.9K shares at avg. $44.35$704K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 |  EXEL EXELIXIS, INC. | Award | 8,367 | - | $0 | Direct |
| Apr 7, 2026 |  OVID Ovid Therapeutics Inc. | Award | 17,578 | $2.56 | $45,000 | Direct |
| Feb 26, 2026 | OVID Ovid Therapeutics Inc. | Award Employee Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Nov 12, 2025 | EXEL EXELIXIS, INC. | Sale | 100,000 | $43.55 | $4,355,000 | Direct |
| Jun 25, 2025 |  RGLS Regulus Therapeutics Inc. | Tender Offer | 976,253 | - | - | Direct |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Disposition | 64,635 | - | - | Direct |
| May 29, 2025 | EXEL EXELIXIS, INC. | Award | 9,812 | - | - | Direct |
| May 15, 2025 | EXEL EXELIXIS, INC. | Exercise | 20,634 | $19.77 | $407,934 | Direct |
| May 15, 2025 | EXEL EXELIXIS, INC. | Exercise | 15,874 | $20.50 | $325,417 | Direct |
| May 15, 2025 | EXEL EXELIXIS, INC. | Sale | 15,874 | $44.35 | $704,012 | Direct |
1-10 of 13 transactions